Siga Technologies

FDA

Nov 06, 2018

FDA approves Zulresso; Pfizer receives approval; Novartis relinquishes Rituxan

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper